NCT00405652View on ClinicalTrials.gov

Measurement of Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Liver Transplantation
Interventions
DRUG

Enteric-coated Mycophenolate sodium (EC-MPS)

experimental

Trial Locations (1)

Unknown

Novartis Investigative Site, Nuremberg

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY